{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["12(4)"],"submitter":["Nooka AK"],"funding":["Janssen Oncology","NCI NIH HHS"],"journal":["Blood cancer journal"],"pagination":["63"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9007985"],"repository":["biostudies-literature"],"pubmed_title":["Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN."],"pmcid":["PMC9007985"],"funding_grant_id":["UG1 CA233180","UG1 CA233339"],"pubmed_authors":["Bartlett JB","Vermeulen J","Voorhees P","Shune L","Lin TS","Rodriguez C","Reeves B","Pei H","Jakubowiak A","Anderson LD","Nooka AK","Kaufman JL","Efebera Y","Chari A","Cortoos A","Patel S","Richardson PG","Badros A","Wildes T","Holstein SA"],"additional_accession":[]},"is_claimable":false,"name":"Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN.","description":null,"dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Apr","modification":"2026-05-31T12:58:42.449Z","creation":"2025-04-06T21:51:33.374Z"},"accession":"S-EPMC9007985","cross_references":{"pubmed":["35418120"],"doi":["10.1038/s41408-022-00653-1"]}}